Xencor Depreciation & Amortization 2011-2026 | XNCR

Annual Depreciation & Amortization Xencor

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
10.5 M	12.1 M	11.5 M	8.8 M	7.49 M	5.79 M	4.3 M	3.25 M	2.03 M	1.47 M	1.11 M	882 K	711 K	527 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
12.1 M	527 K	5.03 M

Quarterly Depreciation & Amortization Xencor

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
2.4 M	2.4 M	2.69 M	-	2.8 M	2.7 M	3.04 M	-	-	-	2.24 M	-	6.64 M	-	2.18 M	-	5.38 M	-	1.64 M	-	4.26 M	2.82 M	1.37 M	-	3.07 M	2 M	996 K	-	2.37 M	1.55 M	730 K	-	1.42 M	864 K	410 K	-	999 K	628 K	282 K	-	768 K	494 K	240 K	-	621 K	486 K	320 K	-	433 K	299 K	139 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
6.64 M	139 K	1.76 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Autolus Therapeutics plc AUTL	8.3 M	$ 1.39	-0.36 %	$ 370 M	Britain
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Aytu BioScience AYTU	5.38 M	$ 2.58	-3.2 %	$ 16.2 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Coherus BioSciences CHRS	1.3 M	$ 1.64	-2.1 %	$ 192 M	USA
Akari Therapeutics, Plc AKTX	14 K	$ 3.4	-3.95 %	$ 229 B	Britain
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Alnylam Pharmaceuticals ALNY	55.7 M	$ 321.48	-2.68 %	$ 42.1 B	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aptorum Group Limited APM	1.13 M	$ 0.88	-0.58 %	$ 4.8 M	China
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Cerus Corporation CERS	1.43 M	$ 1.88	1.35 %	$ 358 M	USA
AbbVie ABBV	762 M	$ 205.21	-0.69 %	$ 363 B	USA
Aquestive Therapeutics AQST	548 K	$ 4.09	-	$ 437 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
AbCellera Biologics ABCL	18.4 M	$ 3.34	-1.62 %	$ 998 M	Canada
Arcturus Therapeutics Holdings ARCT	3.02 M	$ 8.41	2.37 %	$ 230 M	Israel